Subject: CIIX CFO to Run Wholly-owned Subsidiary, CBD Biotech

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CIIX CFO to Run Wholly-owned Subsidiary, CBD Biotech
Hot Stock to WatchHot Stock to Watch

Company: (OTCQB: CIIX)


Price: 0.545

Change (%): - 0.005 (0.91)

Volume: 38,638
CIIX Chart, Inc. Taps Chief Financial Officer for its Wholly-owned Subsidiary, CBD Biotech

SAN GABRIEL, California, December 18, 2018 /PRNewswire/ -, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced the appointment of Alex Hamilton, as Chief Financial Officer of its wholly-owned subsidiary, CBD Biotechnology, LTD. Mr. Hamilton’s focus will be on the execution of the previously announced spin-off of CBD Biotech, as well as overseeing a variety of corporate functions, including accounting, business operations and pricing, financial planning and analysis, financial reporting, investor relations, internal Audit, SEC reporting, tax and treasury functions.

“I am humbled by this appointment and look forward to unlocking a lot of value with the spin-off,” says Mr. Hamilton. “This is an exciting opportunity with rapid growth, a first-to-market advantage and a way to benefit to from the largest market ever, the Chinese mainland population.”

Through Mr. Wang’s continued leadership as CEO of CIIX, Mr. Hamilton’s leadership as the CFO of CBD Biotechnology coupled with Summer Yun’s leadership as the CEO of CBD Biotechnology, the Company hopes to refocus on its core financial services/media business. Mr. Hamilton has spent the previous five years as an consultant, serving as Founder and CEO of Hamilton Strategy Group.

“We are all energized by the appointment of Alex Hamilton as the CFO of CBD Biotech,” says Mr. Wang. “Mr. Hamilton is a seasoned financial executive, a veteran of Wall Street with over 20 years of experience, strategic advisor, entrepreneur and investor. I am confident he will lead the company through a seamless transition and beyond.”

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks